18108-1-AP

antibody from Proteintech Group

Targeting: CXCL17 Dcip1, DMC, UNQ473, VCC1

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

18108-1-AP

Provider

Proteintech Group

Product name

CXCL17 antibody

Antibody type

Polyclonal

Description

CXCL17 antibody (Cat. #18108-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Single-cell transcriptome analysis reveals DNMT1(+) epithelial cells promote lymphatic metastasis via CXCL17-mediated TAM infiltration.

Yang G, Liu J, Guo T, Zhu J, Li T, Sun Y, Qin Z, Gan J, Li X, He W
Journal of translational medicine 2026 Mar 17;24(1)

---

Clinical significance of CXCL17 in cervical cancer.

Zhai J, Pang T, An Y, Wang J, Zhang X, Zhang L, Zhang L, Dong L
Medicine 2026 Jan 2;105(1):e46178

---

SNRPC promotes chemoresistance in Wilms tumor via the NF-κB-CXCL17 axis regulating M2-Type TAMs infiltration and targeted nanotherapy research.

Kong X, Lei L, Jin L, Ren C, Mi T, Wang Q, He D
Journal of experimental & clinical cancer research : CR 2026 Feb 28;45(1)

---

OCT4 promotes lung cancer progression through upregulation of VEGF-correlated chemokine-1.

Su BH, Wang CT, Chang JM, Chen HY, Huang TH, Yen YT, Tseng YL, Chang MY, Lee CH, Cheng LH, Wu YC, Wu CL, Ling P, Shiau AL
International journal of medical sciences 2025;22(3):680-695

---

A novel tumor microenvironment-related gene signature for prognostic prediction of intrahepatic cholangiocarcinoma.

Xu D, Lin H, Ma X, Sun Y, Wang W, Wang L
Scientific reports 2025 Nov 24;15(1):41570

---

OTX2 expression contributes progression of gastric cancer in young adults.

Zhai J, Lyu T, Guo Y, An Y, Xiang Y, Xie L, Zeng C
Scientific reports 2025 May 9;15(1):16146

---

Loss of CCL28 and CXCL17 Expression and Increase in CCR1 Expression May Be Related to Malignant Transformation of LGBLEL into Lymphoma.

Liu R, Ma M, Li J, Luan F, Ren T, Wang N, Ma J
Current issues in molecular biology 2024 Sep 29;46(10):10969-10990

---

EVA1B facilitates esophageal squamous carcinoma progression and recruitment of immunosuppressive myeloid-derived suppressor cells in the tumor microenvironment.

Xia T, Zhang Y, Peng H, Jia X, Yang D, Wei L, Li T, Yao W
Pharmacological research 2024 Dec;210:107521

---

Sequencing and Bioinformatics analysis of lncRNA/circRNA-miRNA-mRNA in Glioblastoma multiforme.

Wang R, Li Q, Chu X, Li N, Liang H, He F
Metabolic brain disease 2023 Oct;38(7):2289-2300

---

A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma.

Jiang Z, Luo Y, Zhang L, Li H, Pan C, Yang H, Cheng T, Chen J
Cancers 2022 Jul 30;14(15)

---

Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis.

Zhang X, Peng L, Luo Y, Zhang S, Pu Y, Chen Y, Guo W, Yao J, Shao M, Fan W, Cui Q, Xi Y, Sun Y, Niu X, Zhao X, Chen L, Wang Y, Liu Y, Yang X, Wang C, Zhong C, Tan W, Wang J, Wu C, Lin D
Nature communications 2021 Sep 6;12(1):5291

---

CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.

Shimada S, Makino K, Jinnin M, Sawamura S, Kawano Y, Ide M, Kajihara I, Makino T, Fukushima S, Ihn H
Journal of dermatological science 2020 Dec;100(3):183-191